Table 1 The clinical information of ESCC patients
Characteristics | Groups | Numbers (n = 42) | circ_NRIP1 expression | ||
|---|---|---|---|---|---|
High | Low | P-value | |||
Age |  ≤ 63 | 23 | 11 (47.8%) | 12 (52.2%) | 0.652 |
 > 63 | 19 | 10 (52.6%) | 9 (47.4%) | ||
Gender | Male | 24 | 13 (54.2%) | 11 (45.8%) | 0.723 |
Female | 18 | 8 (44.4%) | 10 (55.6%) | ||
TNM Stage | pT1-pT2 | 19 | 2 (10.5%) | 17 (89.5%) | 0.016 |
pT3-pT4 | 23 | 19 (82.6%) | 4 (17.4%) | ||
Cancer location | Upper | 7 | 4 (57.1%) | 3 (42.9%) | 0.541 |
Middle | 25 | 13 (52.0%) | 12 (48.0%) | ||
Lower | 10 | 4 (40.0%) | 6 (60.0%) | ||
Treatment | No | 42 | 21 (50.0%) | 21 (50.%) | Â |